Re Evaluation of the Efficacy of Azacitidine (AZA) In Patients From the AZA 001 Study with Higher Risk Myelodysplastic Syndromes (MDS) Classified by WHO Criteria and WPSS Risk

Norbert Gattermann; Guillermo F. Sanz; Aristoteles Giagounidis; John F. Seymour; Pierre Fenaux; Valeria Santini; Ghulam J. Mufti; Petra Muus; Fernando Ramos; Lela M. Lucy; C. L. Beach; Lewis R. Silverman

Re Evaluation of the Efficacy of Azacitidine (AZA) In Patients From the AZA 001 Study with Higher Risk Myelodysplastic Syndromes (MDS) Classified by WHO Criteria and WPSS Risk

Norbert Gattermann, Guillermo F. Sanz, Aristoteles Giagounidis, John F. Seymour, Pierre Fenaux, Valeria Santini, Ghulam J. Mufti, Petra Muus, Fernando Ramos, Lela M. Lucy, C. L. Beach, Lewis R. Silverman

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	1643 - 1644
Number of pages	2
Journal	Blood
Volume	116
Issue number	21
Publication status	Published - 2010

Cite this

Gattermann, N., Sanz, G. F., Giagounidis, A., Seymour, J. F., Fenaux, P., Santini, V., Mufti, G. J., Muus, P., Ramos, F., Lucy, L. M., Beach, C. L., & Silverman, L. R. (2010). Re Evaluation of the Efficacy of Azacitidine (AZA) In Patients From the AZA 001 Study with Higher Risk Myelodysplastic Syndromes (MDS) Classified by WHO Criteria and WPSS Risk. Blood, 116(21), 1643 - 1644.

@article{f08a0aaee3ba4e58920389298fac4b83,

title = "Re Evaluation of the Efficacy of Azacitidine (AZA) In Patients From the AZA 001 Study with Higher Risk Myelodysplastic Syndromes (MDS) Classified by WHO Criteria and WPSS Risk",

author = "Norbert Gattermann and Sanz, {Guillermo F.} and Aristoteles Giagounidis and Seymour, {John F.} and Pierre Fenaux and Valeria Santini and Mufti, {Ghulam J.} and Petra Muus and Fernando Ramos and Lucy, {Lela M.} and Beach, {C. L.} and Silverman, {Lewis R.}",

year = "2010",

language = "English",

volume = "116",

pages = "1643 -- 1644",

journal = "Blood",

issn = "1528-0020",

publisher = "American Society of Hematology",

number = "21",

}

TY - JOUR

T1 - Re Evaluation of the Efficacy of Azacitidine (AZA) In Patients From the AZA 001 Study with Higher Risk Myelodysplastic Syndromes (MDS) Classified by WHO Criteria and WPSS Risk

AU - Gattermann, Norbert

AU - Sanz, Guillermo F.

AU - Giagounidis, Aristoteles

AU - Seymour, John F.

AU - Fenaux, Pierre

AU - Santini, Valeria

AU - Mufti, Ghulam J.

AU - Muus, Petra

AU - Ramos, Fernando

AU - Lucy, Lela M.

AU - Beach, C. L.

AU - Silverman, Lewis R.

PY - 2010

Y1 - 2010

M3 - Meeting abstract

SN - 1528-0020

VL - 116

SP - 1643

EP - 1644

JO - Blood

JF - Blood

IS - 21

ER -